Selected Talks

American Society of Nephrology (ASN) Renal Week
San Diego, CA, November, 2006


TBA 		Nocturnal and Frequent Dialysis: Are These the Preferred Therapies for Patients with Cardiovascular Disease?
Christopher C. Chan, MD.


TBA 		Sudden Death in Hemodialysis Patients: Epidemiology
Blanche M. Chavers, MD.
Diabetes and Non-insulin Management in CKD
Katherine R. Tuttle, MD.


1.5 		Obesity and Outcomes in Dialysis Patients
Kamyar Kalantar-Zadeh, MD, PhD, MPH
Is Obesity a Risk Factor for the Development And Progression of Chronic Kidney Disease?
Srinivasan Beddhu, MD


1.5 		Cocaine and Chronic Kidney Injury
Keith C. Norris, MD
Proton Pump Inhibitors and the Kidney: Critical Review
Mark A. Perazella, MD


1.5 		Characteristics of the Long-Term Peritoneal Dialysis Patient
John M. Burkart, MD
Prospects and Challenges for a Staphylococcal Vaccine
Michael K. Hise, MD


1.5 		Alternatives to Vancomycin in the Treatment of Gram-Positive Cocci
Joseph R. Lentino, MD, PhD.
Overview of Catheter Lock Solutions
Michael Allon, MD.


1.0 		Are ACE-I and ARBs Essential for Renoprotection? Debate
Hans Henrik Parving, MD; George Bakris, MD.


2.0 		Bone and Mineral Metabolism in CKD: Medical Crossfire
Hartmut H. Malluche, MD; Stuart M. Sprague, DO; Dennis L. Andress, MD (Moderator: Peter Salgo, MD).


1.5 		Fluid Dysregulation: Disturbances and Management
Robert W. Schrier, MD; Arthur Greenberg, MD.


1.0 		Managing CMV Infections in Transplantation
Robert S. Gaston, MD; Daniel C. Brennan, MD. (Moderator: David Roth, MD).


1.5 		Inflammation in CKD: Biomarkers, Morbidity and Therapy
George A. Kaysen, MD, PhD; Mark J. Sarnak, MD; Peter Stenvinkel, MD, PhD.


1.5 		The CKD that Follows Renal Transplantation: How to Best Manage these Patients
Anil Chandraker, MD, and Warren L. Kupin, MD. (Moderator: Gabriel Danovitch, MD).


1.5 		The New KDOQI Guidelines for Anemia; A Debate: Should an Upper Hgb Limit be Set and What Should it Be?
Allen R. Nissenson, MD and Daniel W. Coyne, MD. (Moderator: Brian J.G. Pereira, MD).


1.5 		Lupus Nephritis: Defining and Treating Renal Flares
Ronald J. Falk, MD and Gerald B. Appel, MD.


1.5 		New, Tri-Partite Approach to Anemia
John W. Adamson, MD; Stephen Fishbane, MD; Ajay K. Singh, MB, FRCP; (Moderator: Jay B. Wish, MD).


1.5 		Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
Robert N. Foley, MB; Domenic A. Sica, MD. (Moderator: Patrick S. Parfrey, MD)


Please look also at related talks from
2005 ASN Renal Week Talks
2004 ASN Renal Week Talks
2003 ASN Renal Week Talks
2002 ASN Renal Week Talks
2001 ASN Renal Week Talks
2000 ASN Renal Week Talks
1999 ASN Renal Week Talks
1998 ASN Renal Week Talks

  
To disseminate new knowledge regarding basic, translational, and clinical research discoveries in the field of nephrology.
To provide exciting scientific and clinical advances in related disciplines in order to expand the scope of research and clinical care in nephrology.
To discuss contemporary standards and new approaches to clinical care in order to ensure the highest quality of care for patients with renal diseases and related disorders.
To review, update and put into perspective the recent advances in many key areas of general nephrology, dialysis, transplantation, and hypertension.

See Individual Lecture Pages

Each talk, or group of talks, depending on length, is accredited for the appropriate number of AMA PRA Category 1 Credits™. Sometimes talks are organized into groups of two or more and paired with a single CME post-test, which must be completed along with an evaluation form.
Date of Web Release: See individual talks
Credit Eligible Through: See individual talks
Credits/Completion Time: See individual talks
Target Audiences: Physicians, researchers, trainees.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

STATEMENT OF NEED :
Chronic kidney disease affects 30-40 million Americans, of whom several thousand require renal replacement therapy. These selected lectures are chosen by the HDCN editor and ASN Postgraduate Medical Director to reflect those areas of practice of greatest interest to the clinician, and areas where recent progress has occurred. The web extension of these ASN lectures will allow nephrologists and other physicians who were unable to attend the live sessions to gain similar benefit from these presentations.
ACCREDITATION AND DESIGNATION STATEMENTS:
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ASN designates this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

SPONSORSHIP / SUPPORT :
All lectures selected were from Renal Week 2006, and all were put together under supervision of the ASN Scientific Program Committee. Web posting of lectures in the free zone was supported by grants to the ASN from pharmaceutical companies. See each symposium page for details of industry sponsorship and support.
FACULTY DISCLOSURE STATEMENTS :
American Society of Nephrology as well as HDCN have conflict of interest policies that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants. Speaker disclosures are posted on each individual talk page.
DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Speaker disclosure about individual talks is posted on each individual talk page.
DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

USER INSTRUCTIONS:
To complete this educational activity, the user will need Windows or Macintosh operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or the Real Player from Real Media (www.real.com) is required and either can be downloaded for free per instructions on the individual lecture pages. Flash 8.0 is required to see the full-screen slide/audio presentations and the video presentations. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.

For any questions concerning this specific activity please send an email to or email@asn-online.org, or call HDCN at 630-325-3276, Monday through Friday from 10 AM - 4 PM Central Standard Time.

For any general questions concerning ASN CME, please contact the American Society of Nephrology.